Biopsychosocial Factors Associated With Pain and Pain-Related Outcomes in Adults and Children With Sickle Cell Disease: A Multivariable Analysis of the GRNDaD Multicenter Registry.

Sickle cell disease biopsychosocial pain model chronic pain pain interference pain severity

Journal

The journal of pain
ISSN: 1528-8447
Titre abrégé: J Pain
Pays: United States
ID NLM: 100898657

Informations de publication

Date de publication:
Jan 2024
Historique:
received: 20 03 2023
revised: 25 07 2023
accepted: 28 07 2023
pubmed: 7 8 2023
medline: 7 8 2023
entrez: 6 8 2023
Statut: ppublish

Résumé

Pain is the primary symptomatic manifestation of sickle cell disease (SCD), an inherited hemoglobinopathy. The characteristics that influence pain experiences and outcomes in SCD are not fully understood. The primary objective of this study was to use multivariable modeling to examine associations of biopsychosocial variables with a disease-specific measure of pain interference known as pain impact. We conducted a secondary analysis of data from the Global Research Network for Data and Discovery national SCD registry. A total of 657 children and adults with SCD were included in the analysis. This sample was 60% female with a median age of 34 (interquartile range 26-42 years) and a chronic pain prevalence of 64%. The model accounted for 58% of the variance in pain impact. Low social (P < .001) and emotional (P < .001) functioning, increasing age (P = .004), low income (P < .001), and high acute painful episodes (P = .007) were most strongly associated with high pain impact in our multivariable model. Additionally, multivariable modeling of pain severity and physical function in 2 comparable samples of registry participants revealed that increasing age and low social functioning were also strongly associated with higher pain severity and low physical functioning. Overall, the results suggest that social and emotional functioning are more strongly associated with pain impact in individuals with SCD than previously studied biological modifiers such as SCD genotype, hemoglobin, and percentage fetal hemoglobin. Future research using longitudinally collected data is needed to confirm these findings. PERSPECTIVE: This study reveals that psychosocial (ie, social and emotional functioning) and demographic (ie, age) variables may play an important role in predicting pain and pain-related outcomes in SCD. Our findings can inform future multicenter prospective longitudinal studies aimed at identifying modifiable psychosocial predictors of adverse pain outcomes in SCD.

Identifiants

pubmed: 37544393
pii: S1526-5900(23)00494-7
doi: 10.1016/j.jpain.2023.07.029
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

153-164

Informations de copyright

Copyright © 2023 United States Association for the Study of Pain, Inc. Published by Elsevier Inc. All rights reserved.

Auteurs

Martha O Kenney (MO)

Department of Anesthesiology, Division of Pediatric Anesthesiology, Duke University, Durham, North Carolina.

Samuel Wilson (S)

Department of Medicine, Division of Hematology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina; UNC Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Nirmish Shah (N)

Departments of Pediatrics & Hematology, Duke University, Durham, North Carolina.

Andrey Bortsov (A)

Center for Translational Pain Medicine, Duke University, Durham, North Carolina.

Wally R Smith (WR)

Division of General Internal Medicine, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, Virginia.

Jane Little (J)

Department of Medicine, Division of Hematology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina; UNC Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Sophie Lanzkron (S)

Department of Medicine, Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Julie Kanter (J)

Division of Hematology and Oncology, University of Alabama, Birmingham, Alabama.

Susan Padrino (S)

School of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio.

Amma Owusu-Ansah (A)

Department of Pediatrics, Division of Pediatric Hematology Oncology, University Hospitals Rainbow Babies & Children's Hospital, Cleveland, Ohio.

Alice Cohen (A)

Division of Hematology and Oncology, Newark Beth Israel Medical Center, Newark, New Jersey.

Payal Desai (P)

Levin Cancer Institute, Atrium Health, Charlotte, North Carolina.

Deepa Manwani (D)

Department of Pediatrics, Albert Einstein College of Medicine and the Children's Hospital at Montefiore (CHAM), Bronx, New York.

Sana Saif Ur Rehman (SSU)

Department of Medicine, Division of Hematology, Washington University School of Medicine, St. Louis, Missouri.

Ward Hagar (W)

Department of Pediatrics, UCSF Benioff Children's Hospital, Oakland, California.

Francis Keefe (F)

Pain Prevention and Treatment Research Program, Department of Psychiatry and Behavioral Science, Duke University, Durham, North Carolina.

Classifications MeSH